Laparoscopic Pelvic Lymph Node Dissection: Workup

References

1. Baldwin DD, Desai PJ. Laparoscopic pelvic lymph node dissection. In: Bishoff JT, Kavoussi LR, eds. Atlas of Laparoscopic Urologic Surgery. Elseiver;2007:Ch. 20.

2. Bishoff JT, Motley G, Optenberg SA, et al. Incidence of fecal and urinary incontinence following radical perineal and retropubic prostatectomy in a national population. J Urol. Aug 1998;160(2):454-8. [Medline].

3. Brendler CB, Cleeve LK, Anderson EE, Paulson DF. Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol. Dec 1980;124(6):849-50. [Medline].

4. Catalona WJ. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Stamey TA, eds. Campbell's Urology. 6th ed. Philadelphia, Pa: WB Saunders;. 1992:1094-158.

5. Catalona WJ, Stein AJ. Accuracy of frozen section detection of lymph node metastases in prostatic carcinoma. J Urol. Mar 1982;127(3):460-1. [Medline].

6. Corvin S, Schilling D, Eichhorn K, et al. Laparoscopic sentinel lymph node dissection - a novel technique for the staging of prostate cancer. Eur Urol. Feb 2006;49(2):280-5. [Medline].

7. Glascock MJ, Winfield HN. Lymphadenectomy. In: Sosa RE, ed. Textbook of Endourology. Philadelphia, Pa: WB Saunders;. 1997:494-505.

8. Herrell SD, Trachtenberg J, Theodorescu D. Staging pelvic lymphadenectomy for localized carcinoma of the prostate: a comparison of 3 surgical techniques. J Urol. Apr 1997;157(4):1337-9. [Medline].

9. Hricak H. Noninvasive imaging for staging of prostate cancer: magnetic resonance imaging, computed tomography, and ultrasound. NCI Monogr. 1988;31-5. [Medline].

10. Hu JC, Nelson RA, Wilson TG, et al. Perioperative complications of laparoscopic and robotic assisted laparoscopic radical prostatectomy. J Urol. Feb 2006;175(2):541-6; discussion 546. [Medline].

11. Kavoussi LR, Sosa E, Chandhoke P, et al. Complications of laparoscopic pelvic lymph node dissection. J Urol. Feb 1993;149(2):322-5. [Medline].

12. Moore RG, Kavoussi LR. Laparoscopic lymphadenectomy in genitourinary malignancies. Surg Oncol. 1993;2 Suppl 1:51-66. [Medline].

13. Mukamel E, deKernion JB. Early versus delayed lymph-node dissection versus no lymph-node dissection in carcinoma of the penis. Urol Clin North Am. Nov 1987;14(4):707-11. [Medline].

14. Mukamel E, Hannah J, Barbaric Z, deKernion JB. The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: comparison with the clinical and histological staging. J Urol. Dec 1986;136(6):1231-3. [Medline].

15. O''Dowd GJ, Veltri RW, Orozco R, et al. Update on the appropriate staging evaluation for newly diagnosed prostate cancer. J Urol. Sep 1997;158(3 Pt 1):687-98. [Medline].

16. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. May 14 1997;277(18):1445-51. [Medline].

17. Paul DB, Loening SA, Narayana AS, Culp DA. Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. J Urol. Jun 1983;129(6):1141-4. [Medline].

18. Raboy A, Adler H, Albert P. Extraperitoneal endoscopic pelvic lymph node dissection: a review of 125 patients. J Urol. Dec 1997;158(6):2202-4; discussion 2204-5. [Medline].

19. Schellhammer PF, Jordan GH, Schlossberg SM. Tumors of the penis. In: Walsh PC, Retik AB, Stamey TA, eds. Campbell's Urology. 6th ed. Philadelphia, Pa: WB Saunders;. 1992:1094-158.

20. Stone NN, Stock RG, Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol. Nov 1997;158(5):1891-4. [Medline].

21. Thompson IM. Sophisticated imaging techniques in prostate cancer screening. Controversies in the management of prostate cancer: Part 7. 1991;12-19.

22. Wyler SF, Sulser T, Seifert HH, et al. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer. Urology. Oct 2006;68(4):883-7.

Further Reading

Keywords

laparoscopic pelvic lymph node dissection, pelvic lymph node dissection, LPLND, Partin's tables, Partin tables, prostate cancer, PSA, prostate-specific antigen, Partin nomogram, radical prostatectomy

Contributor Information and Disclosures

Author

Jay T Bishoff, MD, Director, Section of Endourology, Department of Urology, Urology San Antonio
Jay T Bishoff, MD is a member of the following medical societies: American Urological Association
Disclosure: Nothing to disclose.

Coauthor(s)

William J Harmon, MD, Director of Minimally Invasive Urologic Surgery, Urology San Antonio, PA, Associate Clinical Professor, Division of Urology, UTHSC, San Antonio, TX
William J Harmon, MD is a member of the following medical societies: American Urological Association and Phi Beta Kappa
Disclosure: Nothing to disclose.

Robert G Moore, MD, Director of Endourology and Minimally Invasive Surgery, Director of Endourology Fellowship, Associate Professor, Department of Surgery, Division of Urology, Saint Louis University
Robert G Moore, MD is a member of the following medical societies: American Urological Association
Disclosure: Nothing to disclose.

Medical Editor

Bradley Fields Schwartz, DO, FACS, Associate Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

CME Editor

J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center
J Stuart Wolf, Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Terumo Corporation Consulting fee Consulting; Omeros Corporation Consulting fee Consulting

Chief Editor

Stephen W Leslie, MD, FACS, Founder and Medical Director of the Lorain Kidney Stone Research Center, Clinical Assistant Professor, Department of Urology, Medical College of Ohio
Stephen W Leslie, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, National Kidney Foundation, and Ohio State Medical Association
Disclosure: Nothing to disclose.